OBJECTIVE: The aim of this study was to determine whether young boys with fragile X syndrome (FXS) exhibit abnormal physiological or behavioral responses to a moderately intense auditory stimulus, as heightened sensory reactivity is believed to contribute to problem behaviors in this population. METHODS: We examined the physiological basis, via heart activity, of auditory startle in young boys with FXS (n = 22) compared with typically developing controls (n = 27). Associations with mental age, behavioral reactivity, and chronological age were examined. RESULTS: Results suggest that older boys with FXS display increased cardiac reactivity to auditory input than younger boys with FXS that distinguishes them from typically developing controls. Higher mental age was associated with decreased latency to react. CONCLUSIONS: Results contribute to increased understanding of the pathology in sensory processing in boys with FXS, which can inform refinement of the phenotype in young children with FXS and aid in the development of efficacious psychopharmacological and/or behavioral interventions.
OBJECTIVE: The aim of this study was to determine whether young boys with fragile X syndrome (FXS) exhibit abnormal physiological or behavioral responses to a moderately intense auditory stimulus, as heightened sensory reactivity is believed to contribute to problem behaviors in this population. METHODS: We examined the physiological basis, via heart activity, of auditory startle in young boys with FXS (n = 22) compared with typically developing controls (n = 27). Associations with mental age, behavioral reactivity, and chronological age were examined. RESULTS: Results suggest that older boys with FXS display increased cardiac reactivity to auditory input than younger boys with FXS that distinguishes them from typically developing controls. Higher mental age was associated with decreased latency to react. CONCLUSIONS: Results contribute to increased understanding of the pathology in sensory processing in boys with FXS, which can inform refinement of the phenotype in young children with FXS and aid in the development of efficacious psychopharmacological and/or behavioral interventions.
Authors: Deborah D Hatton; Stephen R Hooper; Donald B Bailey; Martie L Skinner; Kelly M Sullivan; Anne Wheeler Journal: Am J Med Genet Date: 2002-03-01
Authors: Grace T Baranek; Yuki H Chin; Laura M Greiss Hess; Jann G Yankee; Deborah D Hatton; Stephen R Hooper Journal: Am J Occup Ther Date: 2002 Sep-Oct
Authors: Randi J Hagerman; Lucy J Miller; Jude McGrath-Clarke; Karen Riley; Edward Goldson; Susan W Harris; Jody Simon; Kelly Church; Julie Bonnell; Todd C Ognibene; Daniel N McIntosh Journal: Microsc Res Tech Date: 2002-05-01 Impact factor: 2.769
Authors: Frank J Symons; Renee D Clark; Deborah D Hatton; Martie Skinner; Donald B Bailey Journal: Am J Med Genet A Date: 2003-04-15 Impact factor: 2.802
Authors: P W Frankland; Y Wang; B Rosner; T Shimizu; B W Balleine; E M Dykens; E M Ornitz; A J Silva Journal: Mol Psychiatry Date: 2004-04 Impact factor: 15.992
Authors: Crystal T Engineer; Tracy M Centanni; Kwok W Im; Kimiya C Rahebi; Elizabeth P Buell; Michael P Kilgard Journal: Brain Res Date: 2014-04-05 Impact factor: 3.252
Authors: Julie A Kable; Claire D Coles; Kenneth L Jones; Lyubov Yevtushok; Yaroslav Kulikovsky; Wladimir Wertelecki; Christina D Chambers Journal: Alcohol Clin Exp Res Date: 2016-09-21 Impact factor: 3.455